Evidence map›Paper›PMID 42038541›Full record

ArticleFrontiers in artificial intelligence2026

Machine learning for multiple sclerosis classification and disability prediction using clinical and MRI data.

Paola Valsasina, Loredana Storelli, Nicolò Tedone, Patrizia Pantano, Claudia Piervincenzi, Silvia Tommasin, Antonio Gallo, Manuela Altieri, Gianpaolo Maggi, Nicola De Stefano and 6 more

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Paola ValsasinaNeuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Loredana StorelliNeuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Nicolò TedoneNeuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Patrizia PantanoDepartment of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
Claudia PiervincenziDepartment of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
Silvia TommasinDepartment of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
Antonio GalloFirst Division of Neurology and Neurophysiopathology, AOU Luigi Vanvitelli, Naples, Italy.
Manuela AltieriFirst Division of Neurology and Neurophysiopathology, AOU Luigi Vanvitelli, Naples, Italy.
Gianpaolo MaggiFirst Division of Neurology and Neurophysiopathology, AOU Luigi Vanvitelli, Naples, Italy.
Nicola De StefanoDepartment of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
Alessia BianchiDepartment of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
Marco BattagliniDepartment of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
Giulia MazzettiNeuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Elisabetta PaganiNeuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Maria A RoccaNeuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Massimo FilippiNeuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Multiple sclerosis (MS) is a complex disease characterized by diverse clinical presentations and progression patterns. Accurate classification and prediction of disease severity are crucial for personalized treatment. We applied machine learning (ML) to demographic, clinical and MRI data to distinguish MS patients from healthy controls (HC), classify MS phenotypes and predict disability using the Expanded Disability Status Scale (EDSS) score. Methods: We included 1,554 MS patients and 520 HC from the Italian Neuroimaging Network Initiative repository, all with neurological assessment and brain T2-/3D T1-weighted MRI. Derived MRI features included total and regional T2 lesion volumes (LV), and normalized tissue volumes from cortical and subcortical grey matter (GM), white matter, cerebellum and brainstem. ML models, including support vector machines, multi-layer perceptron networks, Random Forest and Gradient Boosting were trained for classification and prediction tasks. SHAP analysis ranked the most influential variables. Results: ML models achieved 89-96% accuracy in distinguishing MS patients from HC, driven mainly by T2 LV and brainstem/cerebellar GM volumes. Relapsing Discussion: ML models demonstrated high accuracy in detecting MS, differentiating phenotypes, and predicting disability. Integrating demographic, clinical and MRI measures emerges as an effective strategy for patients' classification and disease severity assessment.

Indexed as

artificial intelligenceclassificationmachine learningMRImultiple sclerosis

Identifiers

PMID42038541
PMCPMC13106177

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.